Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380625787> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4380625787 abstract "Abstract Background and Aims The appropriate prescription of dialysate calcium (DCa) concentration for hemodialysis (HD) patients is debated and guidelines are inconsistent. We investigated the association between DCa and all-cause, cardiovascular mortality and sudden cardiac death (SCD). Moreover, we examined the association between serum dialysate calcium gradient (SCa-DCa) and the study outcomes. Method In this historical cohort study, we included adult incident HD patients registered in the clinical database EuCliD® with dialysis initiation between January 1, 2010, and June 30, 2017 (recruitment period) who survived for at least 6 months after starting dialysis (grace period). We observed patients’ outcomes for up to 2 years after the end of the grace period (Figure 1). We categorized patients into 2 groups according to the prescribed DCa in the last 3 months of the grace period (ascertainment period): 1.25 (DCa 1.25) or 1.50 mmol/l (DCa 1.50). We calculated hazard ratio (HR) with 95% confidence intervals (CI) for all study outcomes with Cox Regression. The fully adjusted model included age, sex, ethnicity, diabetes mellitus, cardiovascular disease, liver disease, cancer, vascular access, treatment time, Kt/V, total ultrafiltered volume per session, serum hemoglobin, serum albumin, calcium containing phosphate binders, active vitamin D, Cinacalcet. We added country indicators as random effects. The SCa-DCa (in mEq/l) was calculated as (albumin-correct serum calcium (in mg⁄dl) × 0.5) – (DCa (in mmol/l) × 2) (1). Results We included 12,897 patients with DCa 1.25 and 26,989 patients with DCa 1.50 from 22 countries. The median age was 65 years and the percentage of men was 61% in both groups. In the unadjusted model, patients treated with DCa 1.50 had higher risk of all-cause mortality compared to those treated with DCa 1.25 (HR 1.07 [95% CI 1.01-1.12]. However, this association was not robust when adjusting for potential confounding (HR 1.04 [95% CI 0.97-1.10]). Similarly, we found no evidence of significant adjusted association between DCa and cardiovascular mortality (HR 1.01 [95% CI 0.92-1.11]). We observed a significant adjusted lower association between DCa 1.50 and SCD (HR 0.78 [95% CI 0.65-0.94]). We found significant associations between larger SCa-DCa gradient and all outcomes: all-cause (HR 1.16 per 1 mEq/L increase [95% CI 1.09-1.24]), cardiovascular mortality (HR 1.23 [95% CI 1.12-1.35]) and SCD (HR 1.69 [95% CI 1.41-2.03]). To explore the contribution of gradient components to patients’ risk, we included both DCa and serum calcium level (SCa) in the models. We observed significant associations with all outcomes and SCa, but not with DCa and the interaction between them. In a subgroup analysis of patients with iPTH levels below 130 pg/ml (n = 7,438), we did not find any significant association between DCa and the outcomes. Conclusion In this observational study, no differences in all-cause or cardiovascular mortality were observed with the prescription of DCa 1.50 as compared to 1.25 after adjustment for confounders, whereas the risk of SCD appeared to be lower in the group of DCa 1.50. The association between the SCa-DCa gradient and outcomes appears to be predominantly related to the effect of SCa." @default.
- W4380625787 created "2023-06-15" @default.
- W4380625787 creator A5012460743 @default.
- W4380625787 creator A5012810198 @default.
- W4380625787 creator A5042807286 @default.
- W4380625787 creator A5044800682 @default.
- W4380625787 creator A5054018228 @default.
- W4380625787 creator A5056632247 @default.
- W4380625787 creator A5060048337 @default.
- W4380625787 creator A5080441144 @default.
- W4380625787 date "2023-06-01" @default.
- W4380625787 modified "2023-09-27" @default.
- W4380625787 title "#4465 NO DIFFERENCES IN ALL-CAUSE OR CARDIOVASCULAR MORTALITY BETWEEN DIALYSATE CALCIUM OF 1.25 AND 1.50 MMOL/L: RESULTS FROM A EUROPEAN HEMODIALYSIS COHORT" @default.
- W4380625787 cites W2115641511 @default.
- W4380625787 doi "https://doi.org/10.1093/ndt/gfad063a_4465" @default.
- W4380625787 hasPublicationYear "2023" @default.
- W4380625787 type Work @default.
- W4380625787 citedByCount "0" @default.
- W4380625787 crossrefType "journal-article" @default.
- W4380625787 hasAuthorship W4380625787A5012460743 @default.
- W4380625787 hasAuthorship W4380625787A5012810198 @default.
- W4380625787 hasAuthorship W4380625787A5042807286 @default.
- W4380625787 hasAuthorship W4380625787A5044800682 @default.
- W4380625787 hasAuthorship W4380625787A5054018228 @default.
- W4380625787 hasAuthorship W4380625787A5056632247 @default.
- W4380625787 hasAuthorship W4380625787A5060048337 @default.
- W4380625787 hasAuthorship W4380625787A5080441144 @default.
- W4380625787 hasBestOaLocation W43806257871 @default.
- W4380625787 hasConcept C124490489 @default.
- W4380625787 hasConcept C126322002 @default.
- W4380625787 hasConcept C134018914 @default.
- W4380625787 hasConcept C141071460 @default.
- W4380625787 hasConcept C207103383 @default.
- W4380625787 hasConcept C2778063415 @default.
- W4380625787 hasConcept C2778653478 @default.
- W4380625787 hasConcept C2779978075 @default.
- W4380625787 hasConcept C44249647 @default.
- W4380625787 hasConcept C555293320 @default.
- W4380625787 hasConcept C71924100 @default.
- W4380625787 hasConcept C72563966 @default.
- W4380625787 hasConcept C90924648 @default.
- W4380625787 hasConceptScore W4380625787C124490489 @default.
- W4380625787 hasConceptScore W4380625787C126322002 @default.
- W4380625787 hasConceptScore W4380625787C134018914 @default.
- W4380625787 hasConceptScore W4380625787C141071460 @default.
- W4380625787 hasConceptScore W4380625787C207103383 @default.
- W4380625787 hasConceptScore W4380625787C2778063415 @default.
- W4380625787 hasConceptScore W4380625787C2778653478 @default.
- W4380625787 hasConceptScore W4380625787C2779978075 @default.
- W4380625787 hasConceptScore W4380625787C44249647 @default.
- W4380625787 hasConceptScore W4380625787C555293320 @default.
- W4380625787 hasConceptScore W4380625787C71924100 @default.
- W4380625787 hasConceptScore W4380625787C72563966 @default.
- W4380625787 hasConceptScore W4380625787C90924648 @default.
- W4380625787 hasIssue "Supplement_1" @default.
- W4380625787 hasLocation W43806257871 @default.
- W4380625787 hasOpenAccess W4380625787 @default.
- W4380625787 hasPrimaryLocation W43806257871 @default.
- W4380625787 hasRelatedWork W113810927 @default.
- W4380625787 hasRelatedWork W141873526 @default.
- W4380625787 hasRelatedWork W2119154902 @default.
- W4380625787 hasRelatedWork W2138956445 @default.
- W4380625787 hasRelatedWork W2746183029 @default.
- W4380625787 hasRelatedWork W3035769840 @default.
- W4380625787 hasRelatedWork W3051076900 @default.
- W4380625787 hasRelatedWork W3203248414 @default.
- W4380625787 hasRelatedWork W4200305071 @default.
- W4380625787 hasRelatedWork W4229053620 @default.
- W4380625787 hasVolume "38" @default.
- W4380625787 isParatext "false" @default.
- W4380625787 isRetracted "false" @default.
- W4380625787 workType "article" @default.